Abstract:Sarcopenia and cognitive impairment, two common geriatric syndromes, have mutual causality. Sarcopenia increases the risk of cognitive impairment, and cognitive impairment can also cause sarcopenia, eventually developing into a vicious cycle. Early recognition and intervention of sarcopenia and cognitive impairment are crucial to improve the quality of life of the elderly patients. Biomarkers appear earlier in the body than clinical phenotypes. Therefore, this paper preliminarily discusses the potential common biomarkers of sarcopenia and cognitive impairment from four aspects, including inflammation, hormone, nutrition and growth factors, helping objective and timely identification of individuals with sarcopenia and cognitive impairment.